CD276-CAR-NK Cells therapy(ProCapZoom Biosciences)

N/A

Report date: 2026/04/20 20:01:59

Base Information

Drug NameCD276-CAR-NK Cells therapy(ProCapZoom Biosciences)
Drug Alias NameCD276 CAR-NK(ProCapZoom Biosciences)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy > Chimeric antigen receptor NK cell therapy
Mechanisms of ActionAnti-CD276
TargetsCD276 antigen
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGuangdong ProCapZoom Biosciences Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGuangdong ProCapZoom Biosciences Co Ltd
Inactive CompaniesN/A
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A